Molecular Pathogenesis of Cholangiocarcinoma: Implications for Disease Classification and Therapy
Khaled W. Kabbara, MD, and colleagues, research treatment options for cholangiocarcinoma.
Current Treatment of Burkitt Lymphoma and High-Grade B-Cell Lymphomas
P. Connor Johnson, MD, and Jeremy S. Abramson MD, MMSc, discuss available treatments for patients with Burkitt lymphoma and high-grade B-cell lymphoma.
Weijing Sun, MD, FACP, Reviews Trends in Gastrointestinal Cancer
“...we don’t focus on survivorship enough. It’s important to understand the other factors involved in surviving besides just a treatment.”
The High Cost of Oral Anticancer Drugs: What Does the Future Hold?
ONCOLOGY Co-Editor-in-Chief Julie M. Vose, MD, MBA, explores high drug costs and financial toxicity.
